虚拟门诊通过达标治疗策略提高克罗恩病抗TNF剂量强化成功率
一项多中心回顾性观察性队列研究比较了虚拟门诊与标准门诊随访在因继发性失应答而接受抗TNF剂量强化的克罗恩病患者中的效果。虚拟门诊组治疗成功率(60.9% vs 35.0%,P<0.002)、合适剂量强化率(82.6% vs 40.0%,P<0.001)、紧密疾病监测率(84.1% vs 28.8%,P<0.001)及降阶梯治疗率(21.3% vs 10.0%,P=0.027)均更高,支持虚拟门诊作为达标治疗的有效模式。
要点
- 虚拟门诊较标准门诊显著提高抗TNF剂量强化后的治疗成功率(60.9% vs 35.0%)。
- 虚拟门诊提升合适剂量强化、紧密监测及降阶梯治疗等过程指标。
- 虚拟门诊模式有助优化抗TNF治疗质量并推动达标治疗。
核心结论
- 在因继发性失应答而接受抗TNF剂量强化的克罗恩病患者中,虚拟门诊模式较标准门诊随访获得更高的治疗成功率,并改善治疗过程质量。
研究设计与样本
- 多中心、平行、观察性回顾性队列研究,纳入149例因继发性失应答接受抗TNF剂量强化的克罗恩病患者,虚拟门诊组69例,标准门诊组80例。
主要发现
- 虚拟门诊组治疗成功率为60.9%,标准门诊组为35.0%(P<0.002)。
- 虚拟门诊组合适剂量强化率为82.6%,标准门诊组为40.0%(P<0.001)。
- 虚拟门诊组紧密疾病监测率为84.1%,标准门诊组为28.8%(P<0.001)。
- 虚拟门诊组降阶梯治疗率为21.3%,标准门诊组为10.0%(P=0.027)。
- 虚拟门诊组粪便钙卫蛋白缓解优于标准门诊组(P=0.002)。
临床怎么用
- 对因继发性失应答而接受抗TNF剂量强化的克罗恩病患者,可考虑采用虚拟门诊模式进行随访管理。
- 虚拟门诊模式通过促进合适剂量强化和紧密疾病监测,可能提高抗TNF治疗的成功率与质量。
局限性
- 本研究为回顾性观察性队列研究,可能存在选择偏倚和混杂因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Virtual clinics represent a novel model of care in inflammatory bowel disease. Their effectiveness in promoting high quality use of biologic therapy and facilitating a treat-to-target approach is unknown. AIM: To evaluate clinical and process-driven outcomes in a virtual clinic compared to standard outpatient care amongst patients receiving intensified anti-TNF therapy for secondary loss of response. METHODS: We performed a retrospective multi-centre, parallel, observational cohort study of Crohn's disease patients receiving intensified anti-TNF therapy for secondary loss of response. Objective assessments of disease activity and anti-TNF trough levels at secondary loss of response and during subsequent 6-month semesters, were compared longitudinally between virtual clinic and standard outpatient care cohorts. The primary endpoint was treatment success, with appropriateness of dose intensification, tight disease monitoring and treatment de-escalation representing secondary outcomes. RESULTS: Of 149 patients with similar baseline characteristics, 69 were managed via a virtual clinic and 80 via standard outpatient care. There were higher rates of treatment success in the virtual clinic cohort (60.9 vs 35.0%, P < 0.002). Rates of appropriate dose intensification (82.6% vs 40.0%, P < 0.001), biomarker remission (faecal calprotectin P = 0.002), tight-disease monitoring (84.1% vs 28.8%, P < 0.001) and treatment de-escalation (21.3% vs 10.0%, P = 0.027) also favoured the virtual clinic cohort. CONCLUSION: This study favoured a virtual clinic-led model-of-care over standard outpatient care in facilitating treatment success as part of an effective treat-to-target approach in Crohn's disease. A virtual clinic model-of-care also improved treatment outcomes and quality of use of intensified anti-TNF therapy through processes that promoted appropriate dose intensification and tight-disease monitoring, while encouraging more frequent dose de-escalation.
引用
- Srinivasan A, van Langenberg DR, Little RD, et al. A virtual clinic increases anti-TNF dose intensification success via a treat-to-target approach compared with standard outpatient care in Crohn's disease. Aliment Pharmacol Ther. 2020. PMID: 32379358. doi:10.1111/apt.15742
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。